<i>IRF1</i> expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma-Reference-Cited by-同舟云学术

IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma

Published:2022-11-02 Issue:12 Volume:18 Page:1319-1327
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Zhou Shijie¹,Lu Chunli²,Liu Gan³,Hu Qinsheng⁴,Yang Jinliang¹

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China

2. Department of Dermatology, the Second People’s Hospital of Neijiang, Neijiang, Sichuan, China

3. Department of Cosmetic Dermatology, the First People’s Hospital of Neijiang, Neijiang, Sichuan, China

4. Department of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2141228

Reference36 articles.

1. Melanoma: From Melanocyte to Genetic Alterations and Clinical Options

2. Targeted agents and immunotherapies: optimizing outcomes in melanoma

3. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

4. CD8+ T cell states in human cancer: insights from single-cell analysis

5. CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRF1 suppresses colon cancer proliferation by reducing SPI1-mediated transcriptional activation of GPX4 and promoting ferroptosis;Experimental Cell Research;2023-10